PKR therapy (Cloud Pharmaceuticals)

N/A

Report date: 2025/03/20 09:23:24
NME

Base Information

Drug NamePKR therapy (Cloud Pharmaceuticals)
Drug Alias NameRNA-dependent protein kinase R therapy Cloud Pharmaceuticals Inc
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon-induced, double-stranded RNA-activated protein kinase modulators
TargetsInterferon-induced, double-stranded RNA-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCloud Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCloud Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A